S
Seach Medical Group Ltd
TASE:SEMG
Seach Medical Group Ltd
TASE:SEMG
Price:
321.6
ILS
1.39%
Market Closed
Market Cap:
₪109.4m
Relative Value
The Relative Value of one SEMG stock under the Base Case scenario is 442.79 ILS. Compared to the current market price of 321.6 ILS, Seach Medical Group Ltd is Undervalued by 27%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SEMG
Relative Value
Base Case
442.79
ILS
Undervaluation 27%
S
Multiples Across Competitors
SEMG Competitors Multiples
Seach Medical Group Ltd Competitors
Seach Medical Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
S
|
Seach Medical Group Ltd
TASE:SEMG
|
109.4m ILS | 0.7 | 7.1 | 5.3 | 6.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
567.6B USD | 6 | 21.2 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.1B GBP | 4.9 | 28.4 | 15.8 | 22.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
224.2B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
281.2B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.4B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.4B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
